Anne E. Daigle

643 total citations
17 papers, 526 citations indexed

About

Anne E. Daigle is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Anne E. Daigle has authored 17 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 8 papers in Infectious Diseases and 5 papers in Immunology. Recurrent topics in Anne E. Daigle's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (4 papers). Anne E. Daigle is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (8 papers) and HIV/AIDS Research and Interventions (4 papers). Anne E. Daigle collaborates with scholars based in United States, Canada and Colombia. Anne E. Daigle's co-authors include Leslie L. Robison, Dennis J. Carlo, Richard Trauger, Jonathan D. Buckley, G. Denman Hammond, Robert J. Wells, Denis R. Benjamin, Diane C. Arthur, F. Ferré and Steven P. Richieri and has published in prestigious journals such as Cancer, American Journal of Epidemiology and The Journal of Infectious Diseases.

In The Last Decade

Anne E. Daigle

17 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne E. Daigle United States 12 223 171 140 120 104 17 526
A. Loy Italy 11 183 0.8× 272 1.6× 31 0.2× 49 0.4× 94 0.9× 21 584
Thomas Böhler Germany 14 176 0.8× 109 0.6× 60 0.4× 55 0.5× 212 2.0× 49 629
Christina M. Lalama United States 17 862 3.9× 765 4.5× 81 0.6× 60 0.5× 188 1.8× 36 1.2k
Mark F. Sands United States 8 83 0.4× 81 0.5× 13 0.1× 23 0.2× 108 1.0× 17 525
Stephen Kravcik Canada 11 668 3.0× 666 3.9× 29 0.2× 29 0.2× 128 1.2× 17 941
John L. Fahey United States 9 187 0.8× 177 1.0× 7 0.1× 54 0.5× 97 0.9× 9 630
Simone Becker United States 11 83 0.4× 203 1.2× 15 0.1× 28 0.2× 51 0.5× 13 461
Kathleen Schultz United States 11 177 0.8× 105 0.6× 16 0.1× 30 0.3× 144 1.4× 20 470
P. de Truchis France 10 251 1.1× 351 2.1× 17 0.1× 28 0.2× 32 0.3× 20 589
Bianca Martin United States 12 33 0.1× 79 0.5× 25 0.2× 72 0.6× 305 2.9× 24 757

Countries citing papers authored by Anne E. Daigle

Since Specialization
Citations

This map shows the geographic impact of Anne E. Daigle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E. Daigle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E. Daigle more than expected).

Fields of papers citing papers by Anne E. Daigle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne E. Daigle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E. Daigle. The network helps show where Anne E. Daigle may publish in the future.

Co-authorship network of co-authors of Anne E. Daigle

This figure shows the co-authorship network connecting the top 25 collaborators of Anne E. Daigle. A scholar is included among the top collaborators of Anne E. Daigle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne E. Daigle. Anne E. Daigle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Moss, Ronald B., Richard Trauger, Wieslawa Giermakowska, et al.. (1997). Effect of Immunization With an Inactivated gp120-Depleted HIV-1 Immunogen on β-Chemokine and Cytokine Production in Subjects With HIV-1 Infection. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). 343–350. 27 indexed citations
3.
Moss, Ronald B., Steven P. Richieri, F. Ferré, et al.. (1997). HIV-1-Specific Functional ImmuneMeasurements as Markers ofDisease Progression. Journal of Biomedical Science. 4(4). 127–131. 1 indexed citations
4.
Moss, Ronald B., Steven P. Richieri, F. Ferré, et al.. (1997). HIV-1-specific functional immune measurements as markers of disease progression. Journal of Biomedical Science. 4(4). 127–131. 7 indexed citations
5.
Ferré, F., Ronald B. Moss, Anne E. Daigle, et al.. (1996). Combination Therapies Against HIV-1 Infection: Exploring the Concept of Combining Antiretroviral Drug Treatments with HIV-1 Immune-Based Therapies in Asymptomatic Individuals. . .. AIDS Patient Care and STDs. 10(6). 357–361. 3 indexed citations
6.
Levine, Alexandra M., Susan Groshen, Dennis J. Carlo, et al.. (1996). Initial Studies on Active Immunization of HIV-Infected Subjects Using a gp120-Depleted HIV-1 Immunogen: Long-Term Follow-Up. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 11(4). 351–364. 46 indexed citations
7.
Moss, Ronald B., F. Ferré, Alexandra M. Levine, et al.. (1996). Viral load, CD4 percentage, and delayed-type hypersensitivity in subjects receiving the HIY-1 Immunogen and antiviral drug therapy. Journal of Clinical Immunology. 16(5). 266–271. 16 indexed citations
8.
Trauger, Richard, Anne E. Daigle, Wieslawa Giermakowska, et al.. (1995). Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.. PubMed. 10 Suppl 2. S74–82. 14 indexed citations
9.
Ferré, F., Ronald B. Moss, Anne E. Daigle, et al.. (1995). Viral load in peripheral blood mononuclear cells as surrogate for clinical progression.. PubMed. 10 Suppl 2. S51–6. 17 indexed citations
10.
Trauger, Richard, F. Ferré, Anne E. Daigle, et al.. (1994). Effect of Immunization with Inactivated gp120-Depleted Human Immunodeficiency Virus Type 1 (HIV-1) Immunogen on HIV-1 Immunity, Viral DNA, and Percentage of CD4 Cells. The Journal of Infectious Diseases. 169(6). 1256–1264. 60 indexed citations
11.
Moss, Ronald B., F. Ferré, Richard Trauger, et al.. (1994). Inactivated HIV-1 Immunogen: impact on markers of disease progression.. PubMed. 7 Suppl 1. S21–7. 4 indexed citations
12.
Turner, John L., Richard Trauger, Anne E. Daigle, & Dennis J. Carlo. (1994). HIV-1 immunogen induction of HIV-1-specific delayed-type hypersensitivity. AIDS. 8(10). 1429–1436. 28 indexed citations
13.
14.
Rosen, Jules, Frank C. Hampel, Paul H. Ratner, et al.. (1991). Pentigetide nasal solution: a multicenter study evaluating efficacy and safety in patients with seasonal allergic rhinitis.. PubMed. 67(4). 409–15. 4 indexed citations
15.
Robison, Leslie L., Jonathan D. Buckley, Anne E. Daigle, et al.. (1989). Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the childrens cancer study group). Cancer. 63(10). 1904–1911. 153 indexed citations
16.
Woods, William G., Anne E. Daigle, Raymond J. Hutchinson, & Leslie L. Robison. (1984). Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of childhood acute lymphocytic leukemia. The Journal of Pediatrics. 105(4). 639–644. 20 indexed citations
17.
Robison, Leslie L. & Anne E. Daigle. (1984). CONTROL SELECTION USING RANDOM DIGIT DIALING FOR CASES OF CHILDHOOD CANCER1. American Journal of Epidemiology. 120(1). 164–166. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Loy Breakdown of academic impact, for papers by Thomas Böhler Breakdown of academic impact, for papers by Christina M. Lalama Breakdown of academic impact, for papers by Mark F. Sands Breakdown of academic impact, for papers by Stephen Kravcik Breakdown of academic impact, for papers by John L. Fahey Breakdown of academic impact, for papers by Simone Becker Breakdown of academic impact, for papers by Kathleen Schultz Breakdown of academic impact, for papers by P. de Truchis Breakdown of academic impact, for papers by Bianca Martin
Rankless by CCL
2026